Skip to content

LivaNova LIVN Change in fair value of contingent consideration

Change in fair value of contingent consideration at other companies

Merit Medical Systems logo
Merit Medical SystemsMMSI
-$179K-117%
Globus Medical logo
Globus MedicalGMED
$6.35M+3,704%

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.32B+62.8%

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's change in fair value of contingent consideration.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's change in fair value of contingent consideration?
LivaNova (LIVN) reported change in fair value of contingent consideration of $10.66M in Q1 2026.
How has LivaNova's change in fair value of contingent consideration changed year-over-year?
LivaNova's change in fair value of contingent consideration increased by 1055.6% year-over-year, from $922K to $10.66M.
What does change in fair value of contingent consideration mean?
Represents the non-cash adjustment to the fair value of earn-out provisions or performance-based payments related to past business acquisitions. Fluctuations in this value reflect changes in management's assessment of the probability that specific financial or operational milestones will be met. This metric helps investors understand the impact of acquisition-related liabilities on reported earnings.